{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"GNAQ, a G protein subunit, is recurrently mutated in uveal melanoma.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"11/23/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "31336681",
        "19718445",
        "19078957",
        "21083380",
        "1328859"
      ]
    },
    "description":"The GNAQ Q209L mutation is located in the GTP-binding pocket of the RAS-like domain of the protein. This mutation has been found in choroidal hemangioma and uveal melanoma (PMID: 31336681, 19718445, 21083380). Expression of this mutation in melanocytes and murine fibroblasts demonstrated that it is activating, as measured by increased anchorage-independent growth compared to wildtype (PMID: 1328859, 19078957).",
    "knownEffect":"Gain-of-function"
  },
  "oncogenic":"Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"Q209L",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":2776,
    "hgvs":null,
    "hugoSymbol":"GNAQ",
    "id":null,
    "proteinEnd":209,
    "proteinStart":209,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The GNAQ Q209L mutation is known to be oncogenic.",
  "vus":false
}